SITIME Corp financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data SITIME Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	85.2	84.1	116	219	284	144	203	327
Cost of revenue	49	44.5	58.2	79.3	101	61.9	98.2	152
Gross profit	36.2	39.6	57.9	139	183	82.1	104	175
Research and development	22.8	23.8	31.7	52.1	90.3	97.6	107	119
Selling, general and administrative	21.2	20.6	34.9	54.5	76.5	84	102	117
Operating expenses	44	44.4	66.5	107	167	189	220	242
Operating income	-7.79	-4.87	-8.61	32.8	16.1	-107	-115	-67
Interest expense	1.51	1.71	0.73
Other non-operating income			-0.76	-0.49	-0.1	-0.14	-0.76	-0.16
Pre-tax income	-9.37	-6.62	-9.37	32.4	23.3	-80.4	-93.1	-42.3
Income tax	-0.03	-0.01	0	0.08	0.08	0.15	0.49	0.6
Net income	-9.34	-6.61	-9.37	32.3	23.3	-80.5	-93.6	-42.9
EBITDA	-0.38	3.4	-2.21	40.8	28	-91.1	-85.2	-26.8
EPS, basic	-0.93	-0.63	-0.58	1.70	1.09	-3.63	-4.05	-1.72
EPS, diluted	-0.93	-0.63	-0.58	1.53	1.03	-3.63	-4.05	-1.72
Shares, basic (weighted)	10	10.6	16.1	19	21.2	22.2	23.1	25
Shares, diluted (weighted)	10	10.6	16.1	21.1	22.7	22.2	23.1	25

Balance sheet

	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents			73.5	559	34.6	9.47	6.11	16.8
Receivables	19.2	17.7	23.9	38.4	41.2	21.9	38.2	45
Inventory	20.5	11.9	12.4	23.6	57.7	65.5	76.7	81.6
Other current assets	2.85	0.98	0.72	2.08	2.97	4.08	5.97	7.51
Total current assets	53.1	99.7	113	626	669	623	544	949
Property, plant and equipment	11.3	9.29	11.7	37.9	58.8	54.7	82.5	105
Lease right-of-use assets		9.79	8.89	8.19	10.8	8.26	6.57	4.09
Goodwill					0	87.1	87.1	87.1
Intangible assets	8.14	4.49	2.07	5.98	5.21	177	164	147
Other non-current assets	0.16	0.16	0.16	0.19	6.72	1.32	1.2	1.75
Total assets	72.7	123	136	678	751	952	885	1,295
Accounts payable	5.03	3.87	6.18	13.1	14.9	8.69	22.9	21.3
Accrued liabilities	2.24	1.88	5.36	7.24	6.11	6.36	12.4	14
Short-term debt	46	41
Total current liabilities	58.7	53.3	19.1	37.4	33.8	121	108	84
Lease liabilities		7.94	6.99	6.4	8.15	5.42	3.49	1.13
Other non-current liabilities	0.56			1.93	0.19	122	76.8	54.5
Total liabilities	61.7	61.3	26.1	45.7	42.1	244	185	139
Total debt	46	41
Paid-in capital	58.4	116	173	664	716	796	882	1,381
Retained earnings	-47.4	-54	-63.4	-31.1	-7.87	-88.4	-182	-225
Shareholders' equity	11	62.1	110	632	708	708	700	1,156
Total equity	11	62.1	110	632	708	708	700	1,156
Total liabilities and equity	72.7	123	136	678	751	952	885	1,295
Shares outstanding	10	15	17.2	20.8	21.7	22.7	23.6	26.3

Cash flow statement

	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-9.34	-6.61	-9.37	32.3	23.3	-80.5	-93.6	-42.9
Depreciation and amortization	7.41	8.27	6.4	7.93	11.8	16.1	30.1	40.2
Stock-based compensation	0.83	1.38	16	30	57.4	76.8	92.6	104
Deferred income tax				0	0	0	0	0
Change in receivables	1.69	1.52	-6.26	-14.5	-2.85	19.4	-16.3	-6.83
Change in inventory	-14	8.14	-2.07	-13.1	-37	-9.89	-14.3	-12
Change in payables	-0.65	-1.15	2.61	5.83	2.47	-5.71	6.12	4.3
Cash from operations	-1.05	7.38	16.6	59.1	39.8	8.06	23.2	87.2
Capital expenditures	-2.31	-1.43	-6.1	-30.9	-31.8	-8.95	-36.2	-52
Acquisitions				0	0	-39	0	0
Cash from investing	-5.01	-3.2	-7.79	-33.8	-560	-36.7	64.8	-428
Stock issued		56.4	48.8	461	34	46	50.5	469
Cash from financing	4.85	51.4	1.3	461	-4.52	3.47	-91.3	351
Net change in cash	-1.21	55.5	10.1	486	-525	-25.1	-3.36	10.7
Free cash flow	-3.36	5.95	10.5	28.2	7.96	-0.89	-13	35.1
Interest paid	1.31	2.17	0.8	0
Income taxes paid	0	0	0	0.02	0.06	0.2	0.09	0.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $662.27 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	58.7%	Gross profit / revenue.
Operating margin	-3.9%	Operating income / revenue.
EBITDA margin	4.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.1%	Pre-tax income / revenue.
Net margin	3.0%	Net income / revenue.
FCF margin	18.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	27.3%	Cash from operations / revenue.
Effective tax rate	3.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	1.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.6%	Net income / average total assets.
R&D / revenue	27.2%	Research and development expense / revenue.
SG&A / revenue	31.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	24.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	9.2%	Capital expenditures / revenue.
D&A / revenue	7.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	61.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	23.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	67.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	24.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	275.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	29.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	39.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	64.0%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	27.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	65.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	17.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	60.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	46.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	19.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	56.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	8.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	3.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	9.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	19.4x	Current assets / current liabilities.
Quick ratio	18.3x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	17.5x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	59.1%	Total liabilities / total assets.
Working capital	$2.02B	Current assets - current liabilities.
Goodwill and intangibles / assets	8.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$801.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.19x	Revenue / average total assets.
Fixed asset turnover	4.09x	Revenue / average property, plant and equipment.
Inventory turnover	1.86x	Cost of revenue / average inventory.
Days inventory	196 days	365 x average inventory / cost of revenue.
Receivables turnover	5.27x	Revenue / average receivables.
Days sales outstanding	69 days	365 x average receivables / revenue.
Days payables	55 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	211 days	Days inventory + days sales outstanding - days payables.
FCF conversion	599.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	33.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.51	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$17.02	Revenue / diluted weighted shares.
FCF per share	$3.07	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.65	Cash from operations / diluted weighted shares.
Book value per share	$38.66	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$30.25	Tangible book value / shares outstanding.
Cash per share	$72.46	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$19.92B	Share price x shares outstanding.
Enterprise value	$17.99B	Market cap + total debt - cash - short-term investments.
P/E	1,413x	Market cap / net income. Only when net income is positive.
P/S	42.6x	Market cap / revenue.
P/B	19.4x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	24.8x	Market cap / tangible book value, when positive.
P/FCF	236x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	156x	Market cap / cash from operations, when positive.
EV/Sales	38.5x	Enterprise value / revenue.
EV/EBITDA	971x	Enterprise value / EBITDA, when both are positive.
EV/FCF	213x	Enterprise value / free cash flow, when both are positive.
FCF yield	0.4%	Free cash flow / market cap.
Earnings yield	0.1%	Net income / market cap (the inverse of P/E).

What was SITIME Corp's revenue in fiscal 2025?

SITIME Corp reported revenue of $326.7M for fiscal 2025, 61.2% higher than the year before.

Was SITIME Corp profitable in fiscal 2025?

No. It reported a net loss of $42.9M.

How much free cash flow did SITIME Corp generate in fiscal 2025?

Cash from operations of $87.2M minus capital expenditures of $52.0M left free cash flow of $35.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SITIME Corp